Trial Profile
Efficacy of Olanzapine in Break-through Emesis After Prophylaxis With Dexamethasone, 5-HT3 Receptor Antagonists and Aprepitant Compared to Metoclopramide.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Metoclopramide
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- Acronyms COMFORT
- 07 Dec 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 09 Aug 2010 New trial record